pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 11·1 min read
save

Biopharma’s top scientists and doctors earned eight-figure pay in 2025, still far below CEO salaries

Jun 11, 2026·read at Endpoints ↗Neutral

Endpoints News released a compensation report that ranks the ten highest-paid scientists and doctors in biopharma for 2025.

The list shows that several executives received eight-figure total compensation packages, highlighting that senior scientific leaders can command substantial pay.

Despite the large sums, the report notes that these figures remain well below the multi-hundred-million packages earned by many CEOs in the sector.

The analysis is part of a broader series examining pay trends across the industry and draws on hundreds of disclosed compensation data.

Access to the full article requires a subscription, with limited free reads available.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Biopharma pay report: Top-paid CSOs, CMOs of 2025”

read at Endpoints ↗
82 words · retrieved Jun 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 4h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 8h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 8h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 8h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 10h agoHealth tech investors are looking at bigger betsEndpoints